Ad astra diagnostics, INC. (PLUS) &D for clia-waived ubiquitous early sepsis detection, severity in ambulance, pre-hospital, post- discharge AOI #02+: infection severity and solving sepsis
Active Definitive Contract Awarded Last action
- Contract number
- 75A50124C00053
- Awardee
-
AD Astra Diagnostics, Inc. UEI LED6PKVTAH33
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $6,702,732
Award facts
- Opportunity
-
- BAA22100SOL00003 Solicitation number
- Contract value 47% obligated
-
- $6,702,732.14 Current, with exercised options
- $14,309,221.71 Potential, with all options
- Completion date 50% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 99 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Morrisville, NC, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,702,732 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $5,000,000 |
About this award
AD Astra Diagnostics, Inc., a child entity, was awarded a firm fixed-price definitive contract on September 22, 2024, by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for the development of CLIA-waived ubiquitous early sepsis detection technology. The $14.3 million contract, which carries an ultimate completion date of December 17, 2028, focuses on creating diagnostic solutions that enable sepsis severity assessment and detection across multiple clinical settings, including ambulances, pre-hospital environments, and post-discharge care. The contractor will perform work at its facility in Morrisville, North Carolina under this ceiling-priced engagement supporting ASPR's infection severity and sepsis-solving initiatives.
This award reflects ASPR's strategic focus on enhancing emergency preparedness and response capabilities through innovative diagnostic technologies. The development of rapidly deployable, waived-complexity sepsis detection tools aligns with the agency's mission to improve public health emergency response and outcomes during critical care events. No set-aside designation was applied to this contract award.
Quick answers
Who was awarded contract 75A50124C00053?
75A50124C00053 was awarded to AD Astra Diagnostics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 22, 2024.
How much is contract 75A50124C00053 worth?
The government has obligated $6,702,732 on 75A50124C00053. Its potential value, with all options, is $14,309,222.
Was contract 75A50124C00053 competed?
The extent of competition for 75A50124C00053 was full and open competition. The government received 99 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award